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Abstract 
Endogenous cannabinoids are diffusible lipid ligands of the main cannabinoid receptors type 1 and 2 
(CB1R and CB2R). In the central nervous system endocannabinoids are produced in an activity-
dependent manner and have been identified as retrograde modulators of synaptic transmission. 
Additionally, some neurons display a cell-autonomous slow self-inhibition (SSI) mediated by 
endocannabinoids. In these neurons, repetitive action potential firing triggers the production of 
endocannabinoids, which induce a long-lasting hyperpolarization of the membrane potential, 
rendering the cells less excitable. Different endocannabinoid receptors and effector mechanisms 
have been described underlying SSI in different cell types and brain areas. Here, we investigate SSI in 
neurons of layer 2/3 in the somatosensory cortex. High-frequency bursts of action potentials induced 
SSI in pyramidal cells (PC) and regular spiking non-pyramidal cells (RSNPC), but not in fast-spiking 
interneurons (FS). In RSNPCs the hyperpolarization was accompanied by a change in input resistance 
due to the activation of G protein-coupled inward-rectifying K+ (GIRK) channels. A CB2R-specific 
agonist induced the long-lasting hyperpolarization, whereas preincubation with a CB2R-specific 
inverse agonist suppressed SSI. Additionally, using cannabinoid receptor knockout mice, we found 
that SSI was still intact in CB1R-deficient but abolished in CB2R-deficient mice. Taken together, we 
describe an additional SSI mechanism in which the activity-induced release of endocannabinoids 
activates GIRK channels via CB2Rs. These findings expand our knowledge about cell type-specific 
differential neuronal cannabinoid receptor signaling and suggest CB2R-selective compounds as 
potential therapeutic approaches. 
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Abstract 
Endogenous cannabinoids are diffusible lipid ligands of the main cannabinoid receptors 
type 1 and 2 (CB1R and CB2R). In the central nervous system endocannabinoids are 
produced in an activity-dependent manner and have been identified as retrograde 
modulators of synaptic transmission. Additionally, some neurons display a cell-
autonomous slow self-inhibition (SSI) mediated by endocannabinoids. In these neurons, 
repetitive action potential firing triggers the production of endocannabinoids, which 
induce a long-lasting hyperpolarization of the membrane potential, rendering the cells 
less excitable. Different endocannabinoid receptors and effector mechanisms have been 
described underlying SSI in different cell types and brain areas. Here, we investigate SSI 
in neurons of layer 2/3 in the somatosensory cortex. High-frequency bursts of action 
potentials induced SSI in pyramidal cells (PC) and regular spiking non-pyramidal cells 
(RSNPC), but not in fast-spiking interneurons (FS). In RSNPCs the hyperpolarization was 
accompanied by a change in input resistance due to the activation of G protein-coupled 
inward-rectifying K+ (GIRK) channels. A CB2R-specific agonist induced the long-lasting 
hyperpolarization, whereas preincubation with a CB2R-specific inverse agonist 
suppressed SSI. Additionally, using cannabinoid receptor knockout mice, we found that 
SSI was still intact in CB1R-deficient but abolished in CB2R-deficient mice. Taken 
together, we describe an additional SSI mechanism in which the activity-induced release 
of endocannabinoids activates GIRK channels via CB2Rs. These findings expand our 
knowledge about cell type-specific differential neuronal cannabinoid receptor signaling 
and suggest CB2R-selective compounds as potential therapeutic approaches. 
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1 Introduction 
The endocannabinoid system is one of the main neuromodulatory systems in the 
vertebrate central nervous system (CNS). Endocannabinoids are membrane-derived lipid 
molecules that mainly, albeit not exclusively, exert their effects by acting via G protein-
coupled receptors (GPCR) (Kano, 2009). While CB1Rs are one of the most widely 
expressed GPCRs in the CNS, CB2Rs were traditionally referred to as peripheral 
endocannabinoid receptors, since their expression was primarily detected in cells of the 
immune system (Munro et al., 1993).  
The best-studies effects of endocannabinoids in the CNS are two forms of short-term 
synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and excitation 
(DSE) (Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001). In 
both DSI and DSE, endocannabinoids are produced by the postsynaptic cell and 
retrogradely activate presynaptic CB1Rs. Further, numerous forms of CB1R-dependent 
synaptic long-term plasticity have been described, with endocannabinoids being 
involved in both long-term potentiation (Gómez-Gonzalo et al., 2015; Maglio et al., 
2017; Wang et al., 2016) and long-term depression (Chevaleyre and Castillo, 2003; 
Gerdeman et al., 2002; Safo and Regehr, 2005; Sjöström et al., 2003). However, in 
recent years several publications have provided functional evidence for the presence of 
CB2Rs in cells of the CNS, where CB2Rs exert inhibitory effects (García-Gutiérrez et al., 
2013, 2012; Gong et al., 2006; Kim and Li, 2015; Onaivi, 2007; Stempel et al., 2016).  
In addition to their synaptic effects, a plethora of non-synaptic and cell-autonomous 
forms of endocannabinoid modulation exists (Bacci et al., 2004; den Boon et al., 2012; 
Stempel et al., 2016). For example, layer 2/3 pyramidal neurons and layer 5 low-
threshold spiking (LTS) interneurons in the somatosensory cortex express a CB1R-
dependent form of self-inhibitory plasticity, namely SSI (Bacci et al., 2004; Marinelli et 
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al., 2009). In both cell types, trains of action potentials (APs) were described to induce 
the production of the endocannabinoid 2-arachidonoylglycerol (2-AG) and subsequent 
CB1R activation within the same cell. This leads to a G protein-dependent opening of 
GIRK channels, which hyperpolarizes the cell. In contrast, in hippocampal CA3 pyramidal 
cells, activation of CB2Rs has been shown to cause a long-lasting hyperpolarization of the 
cells that alters local network rhythms (Stempel et al., 2016). This form of self-inhibition 
is phenotypically similar to cortical SSI but depends on the downstream modulation of 
the sodium/bicarbonate co-transporter (NBC). 
At present, it is not known if SSI in different types of cortical neurons exclusively 
depends on CB1Rs or whether CB2Rs may also contribute to its induction. Furthermore, it 
is not clear exactly which cell types are capable of inducing SSI and by which mechanism 
it is implemented.  
In this study, we investigate cell-autonomous SSI in neocortical neurons of the mouse 
somatosensory cortex layer 2/3. We show that trains of APs evoke a long-lasting 
hyperpolarization in pyramidal cells (PCs) and regular spiking non-pyramidal cells 
(RSNPCs), but not in fast spiking interneurons (FS). In RSNPCs, this self-inhibition is 
exclusively mediated by activation of CB2R, demonstrated both by pharmacological tools 
and knockout (KO) mice, and leads to a hyperpolarization via activation of GIRK 
channels. Our findings add to the understanding of the highly complex function of the 
endocannabinoid neuromodulatory system, and provide additional evidence for 
functional expression of CB2R in the CNS.  
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2 Materials and Methods 
2.1 Ethical Statement and Animal Handling 
Animal husbandry and experimental procedures were performed in accordance with the 
guidelines of local authorities (Berlin, Germany), the German Animal Welfare Act, and 
the European Council Directive 86/609/EEC. CB1R- and CB2R-deficient mice (Buckley et 
al., 2000; Zimmer et al., 1999) were maintained on a C57BL/6n genetic background, and 
homozygous KO mice and their wild-type (WT) littermates were obtained from 
heterozygous breeding. Animals were housed on a 12:12h reversed day-night cycle with 
food and water ad libitum. 
2.2 Preparation of brain slices 
Coronal slices were prepared from the somatosensory cortex of C57BL6/n mice, CB1R or 
CB2R KO mice and their WT-littermates aged postnatal day 21-35. Animals were 
anesthetized with isoflurane and decapitated. Brains were removed and transferred to 
ice-cold sucrose-based artificial cerebrospinal fluid (sACSF) containing in mM: 87 NaCl, 
26 NaHCO3, 50 sucrose, 10 glucose, 2.5 KCl, 1.25 NaH2PO4, 3 MgCl2, 0.5 CaCl2. Tissue 
blocks were mounted on a vibratome (Leica VT 1200S, Leica Microsystems), cut at 
300 μm thickness, and stored in an interface chamber. The interface chamber was 
perfused with ACSF containing in mM: 119 NaCl, 26 NaHCO3, 10 glucose, 2.5 KCl, 1 
NaH2PO4, 2.5 CaCl2 and 1.3 MgCl2. Slices were incubated for at least 60 min before 
recordings started. All ACSF solutions were equilibrated with carbogen (95% O2 and 5% 
CO2). 
2.3 Slice electrophysiology 
Whole-cell current-clamp recordings were performed in layer 2/3 of somatosensory 
cortex with a KMeSO3-based intracellular solution (containing in mM: 130 KMeSO3, 10 
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KCl, 10 HEPES, 4 NaCl, 4 Mg-ATP, 0.5 Na-GTP, 5 Na-Phosphocreatine, 0.1 % Biocytin), 
using a Multiclamp 700B amplifier (Molecular Devices). Data were low-pass filtered at 3 
kHz and sampled at 10 kHz. Neurons were identified visually with infrared differential 
interference contract (IR-DIC) optics on an Olympus BX-51 WI microscope. Interneurons 
were differentiated from PCs based on two criteria: a lack of apical dendrite projecting 
towards the pial surface, and horizontally orientated and spherical shaped somata 
compared to the pyramidal shaped somata of PCs. Experiments were only performed if 
cells had a resting membrane potential more hyperpolarized than -55 mV (without 
correction for liquid junction potential) and a series resistance below 25 MΩ. Bridge 
balance and pipette capacitance compensation was performed throughout the 
recording. Cells were characterized by recording their membrane response and firing 
pattern by applying hyperpolarizing and depolarizing current steps (-200 to + 600 pA, 
increment: 40 pA, 1 s). Fast-spiking interneurons showed high frequency AP firing (>200 
Hz) with no frequency adaptation. Both RSNPCs and PCs showed moderate spiking 
frequency (20 – 60 Hz) and increasing inter-spike intervals during the depolarization 
step. The AP slope ratio was calculated by dividing maximal positive slope with the 
maximal negative slope of the AP. Before inducing SSI, we manually adjusted the 
membrane potential to -60 mV by continuous somatic current injection and recorded a 
stable baseline for 2 min. Cells that did not reach a stable baseline were excluded. SSI 
was induced either by eliciting AP trains with 2 ms long somatic current injection (10 AP 
trains, 20 s inter-train interval; 50 APs/train at 100 Hz) or by bath application of the CB2R 
agonist HU-308 (1 µM, Tocris). Other pharmacological agents (10 µM SCH23390, Tocris; 
10µM S0589, Sigma-Aldrich; 1 µM SR 144528, Tocris) were applied to the bath and brain 
slices were preincubated for at least 10 min before recordings were performed. The 
input resistance was monitored by a 400 ms test-pulse of -40 pA every 20 s.  
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2.4 Data analysis and statistics 
Data were recorded and analyzed with Igor Pro (Wavemetrics) and Neuromatic 
software. Changes in membrane potential (Vm) were calculated by subtracting the 
average membrane potential of 2 min, 60 s after the last AP train, from the baseline 
membrane potential. Changes in input resistance after SSI were calculated by 
normalizing the average input resistance after SSI induction to the average baseline 
input resistance. Cells were classified as responsive when Vm was higher than three 
times the standard deviation of the baseline. Sample size is given as the number of 
recorded cells (n). D’Agostino-Pearson normality test was performed to test individual 
datasets for normal distribution of the data points. Normally distributed datasets were 
compared using a two-tailed Student’s t-test. Stated p-values refer to comparison of 
hyperpolarization amplitude (Vm) between different datasets by using Student’s t-test, 
unless otherwise stated. If datasets were not normally distributed a Mann-Whitney test 
was performed to compare the groups. Data are presented as mean ± standard error of 
the mean (SEM). Box plots are shown as median with 25th and 75th percentile.  
2.5 Morphological reconstruction 
Biocytin-containing intracellular solution (0.1 % Biocytin) was used for post-hoc 
identification of the recorded neuron. After the recording, the brain slices were fixed 
overnight in 4% paraformaldehyde in PBS (pH 7.4) at 4°C before subsequent 
visualization with streptavidin conjugated with Alexa-488 (RRID:AB_2315383). Stained 
slices were imaged with a laser confocal microscope (Leica SP5 on a Leica DMI 6000) 
using a 20x or 63x objective and a z-step size of 1 µm. Morphological reconstruction was 
performed using Neutube (Feng et al., 2015) and Fiji software (Schindelin et al., 2012). 
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3 Results 
3.1 Cell type-specific hyperpolarization  
We performed whole-cell patch-clamp recordings from different cell types of layer 2/3 
in the somatosensory cortex. Based on their appearance in the IR-DIC image, we 
identified PCs by their eponymous soma shape and a prominent apical dendrite 
projecting towards the pial surface (Fig. 1A). Interneurons were differentiated by their 
horizontally orientated or spherical shaped somata and the absence of a prominent 
apical dendrite (Fig. 1B, 1C). Interneurons were further differentiated according to their 
firing properties (Table 1) into RSNPCs (Fig 1B) and FS interneurons (Fig. 1C). 
Physiological properties and firing patterns of PCs and RSNPCs were very similar (Table 
1). In contrast, FS had a lower input resistance and showed a characteristic firing pattern 
(shorter AP half-width and high frequency firing), which allowed distinguishing these 
neurons from PCs and RSNPCs (Table 1). 
Trains of APs elicited long-lasting SSI in PCs (Fig. 1D, G, J: Vm: -4.1 ± 1.5 mV) and in 
RSNPCs (Fig. 1E, H, K: Vm: -5.6 ± 1.1 mV), but not in FS interneurons (Fig. 1F, I, L: Vm: -
0.7 ± 0.5 mV).  
According to our criteria (see Methods), 73 % (8/11) of PCs and 71% (15/21) of RSNPCs 
exhibited a significant hyperpolarization after AP trains, whereas none of the FS were 
responsive. Here, both responsive and non-responsive cells were included in averaged 
values and statistics (Fig. 1). Taken into account only responsive cells, PCs hyperpolarize 
by -6.0 ± 1.6 mV and RSNPCs by -7.6 ± 1.0 mV (data not shown). 
Thus, trains of APs induced a long-lasting hyperpolarization exclusively in regular spiking 
cells (PCs and RSNPCs) in layer 2/3 of the somatosensory cortex, but not in FS 
interneurons. We also assessed the stability of SSI and found that the SSI induced 
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hyperpolarization of the membrane potential in RSNPCs was stable and lasted for the 
entire recording period of up to 40 min after induction (Suppl. Fig. 1A). Additional AP 
trains with an interval of two minutes that were applied after SSI had stabilized did not 
lead to any further significant additional hyperpolarization of the cells (Suppl. Fig. 1B and 
C). 
 
3.2 Mechanism underlying long-lasting hyperpolarization in regular spiking non-
pyramidal neurons 
We have previously shown that trains of APs induce a cell-autonomous CB2R-dependent 
SSI in hippocampal PCs by activation of a sodium/bicarbonate co-transporter (NBC) 
(Stempel et al. 2016). In contrast, both layer 2/3 PCs and layer 5 interneurons of the 
somatosensory cortex utilize an alternative mechanism in which activation of CB1Rs 
induces a GIRK channel-driven hyperpolarization (Bacci et al., 2004; Marinelli et al., 
2009). 
The cellular mechanisms of SSI have not been characterized before in layer 2/3 RSNPCs, 
despite the fact that of all cells in layer 2/3, these show the most pronounced SSI (Fig. 
1). Thus, we focused on RSNPCs to further investigate the SSI mechanism: in RSNPCs, the 
magnitude of hyperpolarization correlated with the decrease in input resistance (Fig. 
2A), indicating an increase in ion channel conductance. Preincubation with an inhibitor 
of NBC (10 µM S0589) did not alter SSI in RSNPCs (Vm: -4.4 ± 3.4 mV; n = 13; p = 0.4 
compared to control condition; data not shown). In contrast, preincubation with a GIRK 
channel blocker (10 µM SCH23390) prevented the long-lasting hyperpolarization (Fig. 
2B-D: control Vm: -5.6 ± 1.1 mV; 15/21 responsive cells; SCH23390 Vm: -0.2 ± 1.1 mV; 
1/11 responsive cells). Additionally, application of SCH23390 after SSI induction strongly 
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depolarized the cells and increased input resistance, reversing the AP-induced effects 
(Fig. 2E-F). In contrast, only a weak baseline depolarization occurred when SCH23390 
was applied to non-stimulated RSNPCs (Fig. 2G). 
Thus, the AP-induced hyperpolarization in RSNPCs is mediated via activation of GIRK 
channels and not by the NBC. 
3.3 CB2 receptors mediate SSI  
SSI was previously characterized as an endocannabinoid-dependent mechanism, in 
which either CB1Rs (Bacci et al., 2004; Marinelli et al., 2009) or CB2Rs (Stempel et al., 
2016) induce a long-lasting hyperpolarization after periods of AP firing, via different 
mechanisms. The specific CB2R agonist HU-308 (1 µM) mimicked the AP-induced 
hyperpolarization, whereas application of the endocannabinoid Noladin ether (NE, 300 
nM), which displays selectivity for CB1Rs over CB2Rs (Hanus et al., 2001), did not cause a 
hyperpolarization (Fig. 3A and B: HU-308Vm: -6.0 ± 1.6 mV, 8/11 responding cells; NE: 
Vm: -0.4 ± 0.8 mV, 3/10 responding cells). Additionally, preincubation with the CB2R 
inverse agonist SR 144528 (1 µM) prevented the AP-induced long-lasting 
hyperpolarization (Fig. 3C and D: control Vm: -5.6 ± 1.1 mV, 15/21 responsive cells; SR 
144528: Vm: -0.8 ± 0.6 mV, 3/15 responsive cells) indicating the involvement of CB2R in 
SSI.  
In order to verify this finding, we used transgenic KO mice lacking CB1R or CB2R (CB1R KO 
and CB2R KO) and their corresponding littermates (Buckley et al., 2000; Zimmer et al., 
1999) to further disentangle the involvement of the major cannabinoid receptors in AP-
induced SSI. In both CB1R KO mice and WT-littermates, trains of APs elicited a long-
lasting hyperpolarization of similar magnitude in RSNPCs (Fig. 4A – C: CB1R KO: Vm: -3.7 
± 0.9 mV, 12/17 responsive cells; CB1R WT: Vm: -5.2 ± 1.5 mV, 7/10 responsive cells). In 
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contrast, CB2R-deficient mice showed a marked reduction of SSI, both in the SSI 
amplitude (Fig. 4D and E: CB2R KO: Vm: -0.4 ± 0.6 mV; CB2R WT: Vm: -3.6 ± 0.8 mV) as 
well as in the number of responding cells (Fig. 4F: CB2R KO: 2/12; CB2R WT: 9/12).  
Corresponding phenotypes were also observed in recordings of PCs in transgenic CB-R 
knockout animals: in CB1R-deficient mice and their WT littermates trains of APs induced 
SSI of similar magnitude (CB1R WT: Vm: -3.9 ± 0.9 mV; CB1R KO: Vm: -4.2 ± 1.5 mV; 
Suppl. Fig. 2). In contrast, the genetic deletion of CB2Rs abolishes SSI also in PCs (CB2R 
WT: Vm: -6.1 ± 1.7 mV; CB2R WT: Vm: -0.5 ± 0.6 mV; Suppl. Fig. 2). 
Finally, we tested the specificity of the CB2R agonist HU-308 for inducing a long-lasting 
hyperpolarization in RSNPCs. In CB1R-deficient mice as well as in their corresponding 
littermates, HU-308 application mimicked AP-induced SSI while it failed to hyperpolarize 
RSNPCs in CB2R-deficient mice (Fig. 4G – I: CB1R KO: Vm: -4.9 ± 1.9 mV 7/10 responsive 
cells; CB1R WT: Vm: -5.5 ± 1.6 mV, 7/10 responsive cells; CB2R KO: Vm: 0.5 ± 1.5 mV, 
0/8 responsive cells; CB2R WT: Vm: -4.1 ± 1.8 mV, 7/11 responsive cells). These 
experiments rule out potential off-target effects of HU-308 in the induction of SSI, and 
underlie establish its specificity for CB2R at a concentration of 1 µM. 
Taken together, both pharmacological intervention and genetic ablation of CB2Rs 
confirm the involvement of CB2Rs in SSI of layer 2/3 regular spiking cells, providing 
strong evidence that cell-autonomous activation of CB2Rs and downstream GIRK channel 
opening is mediating the AP-induced self-inhibition in these cell types. 
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4 Discussion 
Here, we show that trains of APs induce SSI in RSNPCs and PCs in layer 2/3 of the 
somatosensory cortex but not in FS interneurons. This cell type-specific expression of SSI 
was also described for layer 5 of the somatosensory cortex, where only LTS 
interneurons, but not FS neurons exhibited SSI (Bacci et al., 2004). In RSNPCs of layer 2/3 
we investigated the underlying mechanism in detail using pharmacological tools as well 
as CB1R- and CB2R-deficient mice. We find that SSI is selectively mediated by CB2Rs in 
both RSNPCs as well as PCs. This is somewhat unexpected as CB1Rs have been previously 
implicated in SSI of PCs in layer 2/3 of somatosensory cortex (Marinelli et al., 2009). 
 Several recent studies have described the role of CB2Rs in cellular auto-inhibition: In 
hippocampal pyramidal neurons CB2Rs mediate SSI after trains of APs (Stempel et al., 
2016). Additionally, intracellular CB2Rs were also shown to reduce firing frequency in 
PCs of the prefrontal cortex (den Boon et al., 2012). Furthermore, application of CB2R 
agonists hyperpolarizes dissociated dopaminergic neurons of the ventral tegmental area 
and inhibits spiking (Zhang et al., 2014). Together these findings illustrate that CB2R 
activation can lead to modifications in excitability in several different cell types and in 
different brain regions.  
What are the signaling events downstream of the endocannabinoid receptors that lead 
to SSI? So far, several mechanisms have been identified: In hippocampal PCs SSI is 
mediated by CB2R-induced NBC transporter activation (Stempel et al., 2016). In contrast, 
CB1R-mediated GIRK channel activation was described as the mechanism responsible for 
SSI in layer 2/3 PCs and layer 5 LTS interneurons (Bacci et al., 2004; Marinelli et al., 
2009). In the present study, we demonstrate a different pathway for SSI in RSNPCs of 
layer 2/3 and show that APs lead to the activation of CB2Rs, resulting in the opening of 
GIRK channels and hyperpolarization of the membrane potential. 
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In addition to the cell type-specific preference for endocannabinoid receptor subtypes in 
SSI activation, divergent intracellular transduction pathways are also employed to 
hyperpolarize the membrane potential. Given the variability of receptor and receptor 
subtype expression across different classes of neurons, it is not surprising that multiple 
mechanisms and downstream signaling cascades are involved in phenomena such as SSI 
(Arey, 2014). Further, several studies have shown that CB2Rs activation can lead to 
selective utilization of different transduction pathways (Atwood et al., 2012; 
Dhopeshwarkar and Mackie, 2016). Thus, cell type specific variations of the intracellular 
signaling machinery may determine which transduction pathway is implemented after 
agonist binding.  
Due to the low CB2R expression levels in neuronal cells under physiological conditions, it 
has been a challenging task to study CNS effects of CB2R. Unspecific CB1R-pharmacology 
(Stempel et al., 2016) and CB2R antibodies of insufficient specificity (Cécyre et al., 2014; 
Marchalant et al., 2014) have previously impeded a convincing discrimination between 
CB1R- and CB2R-mediated effects in the CNS. However, in recent years, evidence 
accumulated suggesting that both CB1- and CB2Rs serve divergent physiological effects. 
Stempel et al. (Stempel et al., 2016) and Chen et al. (Chen et al., 2017) proposed that 
CB1Rs seem to be mainly involved in modulation of synaptic functions while CB2R 
activation results in postsynaptic inhibition. Additionally, microglial CB2R expression was 
shown to be involved and upregulated in a variety of pathological conditions including 
neuroinflammation (Carlisle et al., 2002; Zoppi et al., 2014), stroke (Yu et al., 2015; 
Zarruk et al., 2012), Parkinson’s disease (Concannon et al., 2016, 2015), Alzheimer’s 
(Benito et al., 2003) and Huntington’s disease (Palazuelos et al., 2009). Also, neuronal 
CB2R expression is increased in neuropathic pain (Svíženská et al., 2013) and drug 
addiction (Zhang et al., 2016). Manipulation of CB2R expression in CA1 PC or microglia 
was shown to induce distinct behavioral phenotypes in mice: while microglial CB2Rs 
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were involved in contextual fear memory, overexpression or disruption of CB2Rs in PC 
lowered anxiety levels or enhanced spatial working memory, respectively (Li and Kim, 
2017). Moreover, constitutive deletion of CB2Rs induces a schizophrenic phenotype in 
mice (Ortega-Alvaro et al., 2011), increases aggressive behavior (Rodríguez-Arias et al., 
2015) and modulates drug-seeking behavior for ethanol (Ortega-Álvaro et al., 2015) and 
nicotine (Navarrete et al., 2013). Furthermore, neuronal CB2Rs modulate oscillatory 
activity – more specific theta-gamma-coupling – in the hippocampal formation (Stempel 
et al., 2016). 
According to these data, Pacher and Machoulam (Pacher and Mechoulam, 2011) 
suggested that CB2R signaling might represent a protective system that prevents tissue 
and cell damage. In line with this, the CB2R mediated auto-inhibition described here may 
represent a cell-autonomous feedback loop preventing neurons from damage due to 
excessive excitability. In this study, the SSI-induced hyperpolarization is indiscriminately 
observed in both types of regular spiking neurons. In contrast, fast spiking interneurons 
do not show this phenomenon, which argues in favor of a protective role against 
intolerable amounts of excitation. In addition, on a more speculative note, it is likely that 
RSNPCS belong to a group of interneurons (5-HT3A receptor containing), which 
preferentially synapse onto other interneurons (Tremblay et al., 2016). Thus, silencing 
RSPNCs would lead to disinhibition of interneurons, effectively adding to the excitation 
protection of PCs. The long-term stability of SSI after induction is a further indication 
that it might occur in specific events where neurons must be prevented from excessive 
activity levels for a longer period of time. 
In terms of the physiological relevance of the phenomenon under study, it has been 
shown before that SSI can also be induced with more naturally spaced activity patterns 
than the induction patterns used in this study: physiological spike trains from in vivo 
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recordings were applied in slices and induced SSI in CA3 pyramidal neurons of similar 
magnitude like the more artificial AP trains (Stempel et al., 2016). Similarly, Marinelli et 
al. could reliably induce SSI in cortical PC with spike trains of lower (10 – 50 Hz) 
frequencies (Marinelli et al., 2009). In this context it is noteworthy that for 
somatosensory cortex layer 2/3 regular spiking pyramidal neurons, firing frequencies of 
up to 60 Hz have been reported (Kinnischtzke et al., 2012). Therefore, SSI can already be 
induced by activity patterns of neurons that can occur in vivo. However, the specific role 
of SSI under physiological conditions has to be addressed experimentally in more detail. 
Together with the lack of psychoactive effects upon CB2R activation and other CB1R 
activation-related side effects (Pertwee, 2012), these findings highlight that CB2Rs 
represent an excellent target for drug-discovery research for multiple pathological 
conditions. 
 
5. Conclusion 
Our study describes a new mechanism by which SSI is implemented in neocortical 
neurons. We show that CB2R activation leads to a GIRK channel mediated cell-
autonomous hyperpolarization and provide further evidence for functional CB2Rs in the 
CNS and supporting their role in regulation of neuronal excitability. Future studies 
combining different techniques will aid in disentangling the different roles of CB1Rs and 
CB2Rs, resulting in a better understanding of their functions and helping the discovery of 
specific therapeutic targets for different pathological conditions. 
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Captions 
Fig. 1. Trains of APs induce cell type-specific hyperpolarization in regular firing neurons 
in layer II/III of somatosensory cortex. 
A – C) Characteristic cell morphology and firing pattern of a PC (A), an RSNPC (B) and a 
FS interneuron (C), visualized by post-hoc biocytin staining and reconstruction. Scale bar: 
50 µm; arrow heads depict the direction of the pial surface. Insets show neuron-type-
specific firing patterns evoked by depolarizing current injection (scale bars: 20 mV, 0.2 
s). 
D – I) Single cell examples (D – F) and time course of the average membrane potential (G 
– I) before, during and after ten trains of APs (black lines) in the different cell types. 
J – L) Individual magnitudes of the AP-train induced hyperpolarization. Trains of APs 
induce SSI in PCs (D, G, J; n = 11) and in RSNPCs (E, H, K; n = 21), but not in FS 
interneurons (F, I, L; n = 6).  
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Fig. 2. AP-induced hyperpolarization is accompanied by a reduction in input resistance 
that is mediated by activation of GIRK-channels in RSNPCs. 
A) The amplitude of the hyperpolarization (Vm) correlates with the reduction in input 
resistance (normalized to the pre-AP average; r² = 0.81, p < 0.0001). Inset: example 
traces of -40 pA testpulses before and after AP trains; scale bars: 0.2 s, 5 mV; filled circle 
in the plot depicts example recording. 
B) Inhibition of AP-induced hyperpolarization by preincubation with the GIRK channel 
blocker SCH23390 (10 µM; B; black lines mark AP stimulation). C) SCH23390 reduced the 
average SSI magnitude (*** p = 0.0005, Student’s t-test; control n = 21; SCH23390 n = 
11) as well as percentage of hyperpolarizing cells (D). 
E) Single cell example of the depolarization induced by application of SCH23390 (10 µM) 
after AP-induced SSI, compared to a control recording without SCH23390 application.  
F) Summary of the SCH23390 effect on the membrane potential after SSI induction (n = 
5). 
G) Application of SCH2330 on non-stimulated cells (on baseline) causes only a minor 
depolarization (* p = 0.0159 Mann-Whitney test; on baseline: n = 4; after SSI: n = 5) 
compared to the effect after SSI. 
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Fig. 3. Pharmacological experiments indicate involvement of CB2R in RSNPC SSI. 
A) Time course of the average membrane potential in response to application of the 
specific CB2R agonist HU-308 (1 µM) and the endocannabinoid NE (300 nM) that displays 
a selectivity for CB1Rs over CB2Rs. Agonist application is indicated by the black line. 
B) Individual magnitudes of agonist-induced hyperpolarization. NE does not cause a 
hyperpolarization (** p = 0.005, Mann-Whitney rest; HU-308: n = 10; NE: n = 11). 
C) Time course of the average membrane potential before, during (black lines) and after 
AP trains in presence or absence of the CB2R inverse agonist SR 144528 (1 µM). 
D) Individual magnitudes of AP-induced hyperpolarization in the presence of SR 144528. 
Preincubation with SR 144528 prevents AP-induced hyperpolarization (** p = 0.0019, 
Mann-Whitney rest; SR 144528: n = 15; control: n = 21). 
 
 
Fig. 4. AP-induced hyperpolarization in RSNPCs is absent in CB2R-deficient mice but 
present in CB1R-deficient mice. 
A – C) AP-induced SSI in RSNPCs of CB1R-deficient mice is indistinguishable from SSI in 
WT-littermates (p = 0.4 Student’s t-test; CB1R KO n = 17; CB1R WT n = 10). A) Time course 
of the average membrane potential in WT (open circles) and CB1R KO mice (black 
circles). B) Overview on individual magnitudes of AP-induced hyperpolarization. C) 
Percentage of cells in which AP trains evoked hyperpolarization. AP trains are indicated 
by black bars. 
D – F) Trains of APs failed to induced SSI in CB2R-deficient mice compared to WT-
littermates (** p = 0.0029 Student’s t-test; CB2R KO n = 12; CB2R WT n = 12). D) Time 
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course of the average membrane potential in WT (open circles) and CB2R KO mice (black 
circles). E) Individual magnitudes of the AP-induced hyperpolarization. F) Percentage of 
cells in which AP trains evoked a hyperpolarization. AP trains are indicated by black bars. 
G – I) HU-308 (1 µM) hyperpolarized RSNPCs in CB1R deficient mice and WT-littermates 
of transgenic animals (p = 0.8 Student’s t-test; CB1R KO n = 10; CB1R WT n = 10), but not 
in CB2R-deficient mice (* p = 0.046; CB2R KO n = 8; CB2R WT n = 11). G) Exemplary time 
course of the membrane potential of RSNPCs in response to HU-308 application (black 
line). Note the hyperpolarization in the CB1R KO (black circles), and the lack of 
hyperpolarization in the CB2R KO (black squares). H) Individual magnitudes of agonist-
induced hyperpolarization in different genotypes. I) Percentage of cells in which agonist 
application evoked hyperpolarization. 
 
Table 1: cell properties of cortical neurons in somatosensory cortex layer 2/3 
 
PCs (11) 
 
RSNPCs (21) 
 
FSs (6) 
 
Resting membrane 
potential [mV] 
 
-81.9 ± 2.0 
 
 
-80.6 ± 1.2 
 
 
 
-65.2 ± 1.9 
 
 
Input resistance [MΩ] 
 
153.1 ± 11.6 
 
189.3 ± 13.87 
 
80,6 ± 9.7 
 
AP half-width [ms] 
 
1.0 ± 0.08 
 
1.6 ± 0.1 
 
0.3 ± 0.19 
 
AP threshold [mV] 
 
-33.9 ± 1.3 
 
-36.0 ± 1.0 
 
-46.8 ± 2.6 
 
AP slope ratio 4.5 ± 0.2 4.5 ± 0.2 0.9 ± 0.1 
    
AHP [mV] 
 
-16.7 ± 0.7 
 
-15.0 ± 0.5 
 
-18.1 ± 0.6 
 
Maximal firing  
frequency [Hz] 
 
36.8 ± 2.3 
 
 
41.17 ± 2.3 
 
 
360 ± 39.9 
 
 
Values are given as mean ± SEM, PC: pyramidal cell; RSNPC: regular spiking non-pyramidal cell; FS: 
fast spiking interneuron; AHP: Afterhyperpolarization; numbers of recorded cells are displayed in 
parentheses.  
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